{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-018731","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2021-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.398686+00:00","generated_at":"2026-06-29T21:15:54.392929+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nephros Q2 revenue $2.3M (+44% YoY); net loss improves 35%; acquires GenArraytion, HDF module filed to FDA","bullets":["Net revenue $2.3M (+44% YoY); net loss improved 35% to $1.1M; adjusted EBITDA improved 46% to ($0.8M).","Water filtration segment rev $2.2M (+40% YoY); gross margin 56%; management expects 55-60%.","Acquired GenArraytion, Inc. in July 2021 to expand PCR testing and pathogen detection capabilities.","Filed FDA 510(k) for second-generation HDF Assist Module; anticipates clearance later this year for limited commercial launch.","Cash and equivalents of $8.3M as of June 30, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-018731","json":"https://secwatch.observer/filing/0001493152-21-018731.json","markdown":"https://secwatch.observer/filing/0001493152-21-018731.md","text":"https://secwatch.observer/filing/0001493152-21-018731.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221018731/0001493152-21-018731-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315221018731/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:15:54.392929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}